These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 574471)

  • 1. delta9-Tetrahydrocannabinol and the quasi morphine withdrawal syndrome.
    Chesher GB; Zaluzny SG; Jackson DM; Malor R
    Adv Biosci; 1978 Jul 22-23; 22-23():605-18. PubMed ID: 574471
    [No Abstract]   [Full Text] [Related]  

  • 2. The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.
    Zaluzny SG; Chesher GB; Jackson DM; Malor R
    Psychopharmacology (Berl); 1979 Mar; 61(2):207-16. PubMed ID: 86997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol.
    Chesher GB; Jackson DM
    Pharmacol Biochem Behav; 1985 Jul; 23(1):13-5. PubMed ID: 2994117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between cannabidiol and delta9-THC during abstinence in morphine-dependent rats.
    Hine B; Torrelio M; Gershon S
    Life Sci; 1975 Sep; 17(6):851-7. PubMed ID: 1238886
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Blockade of morphine abstinence by delta9-tetrahydrocannabinol.
    Carder B
    Science; 1975 Nov; 190(4214):590-1. PubMed ID: 1237929
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide.
    Palestine ML; Alatorre E
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):289-99. PubMed ID: 822987
    [No Abstract]   [Full Text] [Related]  

  • 7. Blockade of morphine-withdrawal body shakes by haloperidol.
    Lal H; Numan R
    Life Sci; 1976 Jan; 18(2):163-7. PubMed ID: 943681
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol.
    Bhargava HN
    Eur J Pharmacol; 1976 Mar; 36(1):259-62. PubMed ID: 944134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome.
    Bhargava HN
    Pharmacol Biochem Behav; 1978 Jan; 8(1):7-11. PubMed ID: 564515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.
    Hine B; Friedman E; Torrelio M; Gershon S
    Science; 1975 Feb; 187(4175):443-5. PubMed ID: 1167428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of drugs on barbiturate withdrawal convulsions in the rat.
    Norton PR
    J Pharm Pharmacol; 1970 Oct; 22(10):763-6. PubMed ID: 4394782
    [No Abstract]   [Full Text] [Related]  

  • 12. Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect.
    Valverde O; Noble F; Beslot F; Daugé V; Fournié-Zaluski MC; Roques BP
    Eur J Neurosci; 2001 May; 13(9):1816-24. PubMed ID: 11359533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of the acute alcohol withdrawal syndrome.
    Coleman JH; Evans WE
    Dis Nerv Syst; 1975 Apr; 36(4):151-4. PubMed ID: 234826
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
    Finn DP; Beckett SR; Roe CH; Madjd A; Fone KC; Kendall DA; Marsden CA; Chapman V
    Eur J Neurosci; 2004 Feb; 19(3):678-86. PubMed ID: 14984418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
    Cook SA; Lowe JA; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1150-6. PubMed ID: 9618417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The organic brain syndrome.
    Raft DD; Newmark C; Toomey T
    Am Fam Physician; 1974 Nov; 10(5):119-23. PubMed ID: 4423054
    [No Abstract]   [Full Text] [Related]  

  • 17. Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal.
    Allsop DJ; Lintzeris N; Copeland J; Dunlop A; McGregor IS
    Clin Pharmacol Ther; 2015 Jun; 97(6):571-4. PubMed ID: 25777582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydrocannabinol-attenuated abstinence and induced rotation in morphine-dependent rats: possible involvement of dopamine.
    Hine B; Friedman E; Torrelio M; Gershon S
    Neuropharmacology; 1975 Aug; 14(8):607-10. PubMed ID: 1237098
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.